Literature DB >> 11177690

Liver biopsy: when, how, by whom, and where?

D B McGill1.   

Abstract

Liver biopsy remains an important diagnostic tool in the management of liver disease. Complications, though infrequent, are potentially disastrous. Risks and discomfort can be minimized with good technique, although prospective data to prove the superiority of one method over another are often lacking. Image direction is preferred in all cases, as is a transjugular approach when bleeding risks are judged to be high. Bleeding is essentially a random event. Outpatient liver biopsy is appropriate in almost every instance if immediate hospitalization facilities are available. It should be more widely practiced. Liver biopsies should only be done if, after thoughtful assessment, benefits are thought to exceed risks.

Entities:  

Mesh:

Year:  2001        PMID: 11177690     DOI: 10.1007/s11894-001-0036-1

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  40 in total

1.  Liver biopsy under ultrasound control: implications for training in the Calman era.

Authors:  S Shah; J F Mayberry; A C Wicks; Y Rees; R J Playford
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

2.  Pain experienced during percutaneous liver biopsy.

Authors:  L Castéra; I Nègre; K Samii; C Buffet
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

3.  Transjugular liver biopsy: modified Ross transseptal needle versus quick-core biopsy needle.

Authors:  S W Choo; Y S Do; K B Park; S H Kim; Y H Han; I Choo
Journal:  Abdom Imaging       Date:  2000 Sep-Oct

Review 4.  Liver biopsy.

Authors:  V Desmet; J Fevery
Journal:  Baillieres Clin Gastroenterol       Date:  1995-12

5.  Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs.

Authors:  R J Farrell; P F Smiddy; R M Pilkington; A A Tobin; E E Mooney; I J Temperley; G S McDonald; H A Bowmer; G F Wilson; D Kelleher
Journal:  J Hepatol       Date:  1999-04       Impact factor: 25.083

6.  Outpatient liver biopsy: how safe is it?

Authors:  G Garcia-Tsao; J L Boyer
Journal:  Ann Intern Med       Date:  1993-01-15       Impact factor: 25.391

Review 7.  Liver biopsy in the mid-1990s: questions and answers.

Authors:  D J van Leeuwen; L Wilson; D R Crowe
Journal:  Semin Liver Dis       Date:  1995-11       Impact factor: 6.115

8.  Percutaneous biopsy of the liver as a procedure for outpatients.

Authors:  C M Knauer
Journal:  Gastroenterology       Date:  1978-01       Impact factor: 22.682

9.  Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells.

Authors:  M Louha; J Nicolet; H Zylberberg; A Sabile; C Vons; G Vona; K Poussin; M Tournebize; F Capron; S Pol; D Franco; B Lacour; C Bréchot; P Paterlini-Bréchot
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

10.  Outpatient liver biopsy using ultrasound guidance and the Biopty gun is safe and cost effective.

Authors:  B C Smith; P V Desmond
Journal:  Aust N Z J Med       Date:  1995-06
View more
  3 in total

Review 1.  Feasibility and experience of nurse-led ultrasound-guided percutaneous liver biopsy.

Authors:  Elizabeth Anne Farrington; Giles Maskell; Hyder Syed Hussaini
Journal:  Frontline Gastroenterol       Date:  2012-04-13

2.  Outpatient blind percutaneous liver biopsy in infants and children: is it safe?

Authors:  Mortada H El-Shabrawi; Hanaa M El-Karaksy; Sawsan H Okahsa; Naglaa M Kamal; Gamal El-Batran; Khaled A Badr
Journal:  Saudi J Gastroenterol       Date:  2012 Jan-Feb       Impact factor: 2.485

3.  A quantitative metabolomics profiling approach for the noninvasive assessment of liver histology in patients with chronic hepatitis C.

Authors:  M Omair Sarfaraz; Robert P Myers; Carla S Coffin; Zu-Hua Gao; Abdel Aziz M Shaheen; Pam M Crotty; Ping Zhang; Hans J Vogel; Aalim M Weljie
Journal:  Clin Transl Med       Date:  2016-08-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.